Special guest Carrie Vyhlidal, PhD of KCAS joins John and Dom in the 68th episode of “The Weekly Bioanalysis” to discuss the ways molecular cell & gene therapy services has evolved and why their role will likely become more and more important to the world of bioanalytical drug development in the future. They discuss everything from the history of Cell & Gene Therapies and the topic of replicates, to some of the challenges and pitfalls of GLP research for molecular cell & gene therapy specialists.
To view/listen to the episode of “the Weekly Bioanalysis” click the play button below!
“The Weekly Bioanalysis” is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they’ve learned about the Bioanalytical world the past couple of weeks. The Weekly Bioanalysis is brought to you by KCAS.
KCAS is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA, and Lyon, France, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.
You can always find the latest episode of “The Weekly Bioanalysis” here,
but you can also subscribe to the podcast on Apple Podcasts or any of the major podcast distribution channels!
We would love to hear from you about questions you have from our podcast – or even feedback on how we could improve it!
Please use the form below to reach out to us.